9,9'-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-四羟基-5,12-二氧化八氢-2H,7H-二呋喃并[3,2-d:3',2'-j][1,3,7,9]四氧杂[2,8]二磷环十二-2,9-二基)双(2-氨基-3,9-二氢-6H-嘌呤-6-酮)
Cyclic-di-GMP
| 产品编号.: | A093230 | CAS号: | 61093-23-0 |
| 分子式: | C20H24N10O14P2 | 分子量: | 690.4107 |
| 纯度: | 95% | MDL NO.: |
中文名称：9,9'-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-四羟基-5,12-二氧化八氢-2H,7H-二呋喃并[3,2-d:3',2'-j][1,3,7,9]四氧杂[2,8]二磷环十二-2,9-二基)双(2-氨基-3,9-二氢-6H-嘌呤-6-酮)
CAS号：61093-23-0
中文别名：二(3,5)-环二鸟苷酸;环二鸟苷酸CYCLIC DI-GMP
英文名称：Cyclic-di-GMP
英文别名：bis(3',5')-cyclic diguanylic acid;5'''-nucleotide;CYCLIC BIS ( 3' → 5' ) DIGUANYLIC ACID;CYCLIC DIGUANOSINE MONOPHOSPHATE ( C-DIGMP );Cyclic-di-GMP(c-di-GMP);2-Amino-9-[17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa;Cyclic-di-GMP;c-di-GMP;cyclic di-GMP;cdiGMP;Cyclic diguanylate;3',5'-Cyclic diguanylic acid;cGpGp;c-(Gpgp);Cyclic diguanylic acid;Bis-(3',5')-cyclic diGMP;cyclic di-3',5'-guanylate;Cyclic-bis(3',5')diguanylic acid;5GP-5GP;9,9'-[(2r,3r,3as,5s;9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Dif;cyclic dinucleotide di-GMP;E5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;(1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3,12-diphosphatricyclo[13.3.0.0,octadecane-3,12-dione;61093-23-0;CHEMBL1231573;EX-A6951;cyclic di-3',5'-guanylic acid;2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3;DTXSID801027528;9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One);Bis-(3'-5')-cyclic dimeric guanosine monophosphate;C2E;SCHEMBL17974376;c-di-GMP (disodium);3',5'-cyclic di-GMP;cyclic-bis(3'->5') dimeric GMP;dyclic diguanylate monophosphate;Cyclicdiguanylate;DA-52212;2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;CHEBI:49537;HY-107780;BDBM50436163;GTPL13137;9,9'-[(2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one);AKOS040732890;3',5'-Cyclic diGMP;BP-58810;c-di-GMP; Cyclic diguanosine monophosphate;E5,12;CS-7977;Q2649761;guanylyl-(3'->5')-3'-guanylic acid, cyclic 3'->5'''-nucleotide;(1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-hydroxypurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol
EINEC:
分子式：C20H24N10O14P2
分子量：690.41
CAS号：61093-23-0
中文别名：二(3,5)-环二鸟苷酸;环二鸟苷酸CYCLIC DI-GMP
英文名称：Cyclic-di-GMP
英文别名：bis(3',5')-cyclic diguanylic acid;5'''-nucleotide;CYCLIC BIS ( 3' → 5' ) DIGUANYLIC ACID;CYCLIC DIGUANOSINE MONOPHOSPHATE ( C-DIGMP );Cyclic-di-GMP(c-di-GMP);2-Amino-9-[17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa;Cyclic-di-GMP;c-di-GMP;cyclic di-GMP;cdiGMP;Cyclic diguanylate;3',5'-Cyclic diguanylic acid;cGpGp;c-(Gpgp);Cyclic diguanylic acid;Bis-(3',5')-cyclic diGMP;cyclic di-3',5'-guanylate;Cyclic-bis(3',5')diguanylic acid;5GP-5GP;9,9'-[(2r,3r,3as,5s;9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Dif;cyclic dinucleotide di-GMP;E5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;(1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3,12-diphosphatricyclo[13.3.0.0,octadecane-3,12-dione;61093-23-0;CHEMBL1231573;EX-A6951;cyclic di-3',5'-guanylic acid;2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3;DTXSID801027528;9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One);Bis-(3'-5')-cyclic dimeric guanosine monophosphate;C2E;SCHEMBL17974376;c-di-GMP (disodium);3',5'-cyclic di-GMP;cyclic-bis(3'->5') dimeric GMP;dyclic diguanylate monophosphate;Cyclicdiguanylate;DA-52212;2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;CHEBI:49537;HY-107780;BDBM50436163;GTPL13137;9,9'-[(2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one);AKOS040732890;3',5'-Cyclic diGMP;BP-58810;c-di-GMP; Cyclic diguanosine monophosphate;E5,12;CS-7977;Q2649761;guanylyl-(3'->5')-3'-guanylic acid, cyclic 3'->5'''-nucleotide;(1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-hydroxypurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol
EINEC:
分子式：C20H24N10O14P2
分子量：690.41
搜索质检报告(COA)
搜索MSDS
